Table 4.
Group 0.2% (n = 23) |
Group 0.4% (n = 27) |
|
---|---|---|
Home oral opioid | ||
consumption (mg)* | ||
Postoperative day 1 | 10 (0–20) | 20 (10–30) |
Postoperative day 2 | 10 (5–20) | 15 (5–30) |
Postoperative day 3 | 15 (5–30) | 15 (5–25) |
Awakenings because of | ||
pain (#) | ||
Postoperative day/night 0 | 0 (0–2) | 2 (0–4) |
Postoperative day/night 1 | 0 (0–1) | 0 (0–3) |
Postoperative day/night 2 | 0 (0–2) | 0 (0–1) |
Values are reported as median (25th–75th percentiles).
Oral opioid provided as 5 mg oxycodone tablets. Values include home opioid consumption in the 24-h previous to the daily data-collection phone calls.
Because each comparison dilutes all other P-values, we restricted our analysis to four comparisons among secondary end points. For this reason, no statistical comparisons were applied to the data of this table.